CSIMarket
 


Pfizer Inc  (PFE)
Other Ticker:  
 
 

PFE's Operating Income Growth by Quarter and Year

Pfizer Inc's Operating Income results by quarter and year




PFE Operating Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December 341.00 1,535.00 2,312.00 3,231.00
III Quarter September 3,324.00 11,045.00 3,764.00 1,617.00
II Quarter June 3,091.00 4,266.00 3,976.00 3,021.00
I Quarter March 4,105.00 4,414.00 3,949.00 3,477.00
FY   10,861.00 21,260.00 14,001.00 11,346.00



PFE Operating Income forth quarter 2020 Y/Y Growth Comment
Pfizer Inc reported drop in Operating Income in the forth quarter by -77.79% to $ 341.00 millions, from the same quarter in 2019.
The fall in the forth quarter Pfizer Inc's Operating Income compares unfavorably to the Company's average Operating Income decrease of -0.76%.

Looking into forth quarter results within Major Pharmaceutical Preparations industry 26 other companies have achieved higher Operating Income growth. While Pfizer Inc' s Operating Income meltdown of -77.79% ranks overall at the positon no. 1109 in the forth quarter.

Explain Operating Income growth


PFE Operating Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December -77.79 % -33.61 % -28.44 % -16.96 %
III Quarter September -69.9 % 193.44 % 132.78 % -11.83 %
II Quarter June -27.54 % 7.29 % 31.61 % -10.04 %
I Quarter March -7 % 11.78 % 13.57 % -3.28 %
FY   -48.91 % 51.85 % 23.4 % -10.51 %

Financial Statements
Pfizer Inc's forth quarter 2020 Operating Income $ 341.00 millions PFE's Income Statement
Pfizer Inc's forth quarter 2019 Operating Income $ 1,535.00 millions Quarterly PFE's Income Statement
New: More PFE's historic Operating Income Growth >>


PFE Operating Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December -89.74 % -86.1 % -38.58 % 99.81 %
III Quarter September 7.54 % 158.91 % -5.33 % -46.47 %
II Quarter June -24.7 % -3.35 % 0.68 % -13.11 %
I Quarter March 167.43 % 90.92 % 22.22 % -10.64 %
FY (Year on Year)   -48.91 % 51.85 % 23.4 % -10.51 %




Operating Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #27
Healthcare Sector #97
Overall #1109

Operating Income Y/Y Growth Statistics
High Average Low
49.34 % -0.76 % -49.17 %
(Sep 29 2019)   (Sep. 30, 2015)
Operating Income forth quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #27
Healthcare Sector #97
Overall #1109
Operating Income Y/Y Growth Statistics
High Average Low
49.34 % -0.76 % -49.17 %
(Sep 29 2019)   (Sep. 30, 2015)

Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Pfizer Inc's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
79375 % 1263.57 % -99.9 %
(March 31, 2010)  


PFE's IV. Quarter Q/Q Operating Income Comment
In the IV. Quarter 2020 Pfizer Inc realized fall in Operating Income sequentially by -89.74% to $ 341.00 millions, from $ 3,324.00 millions declared a quarter before.

But that's not important issue, as Pfizer Inc's Operating Income always seem to dip in the IV. Quarter.

Within Major Pharmaceutical Preparations industry 39 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 2102.


Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #40
Healthcare Sector #169
Overall #2102
Operating Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #40
Healthcare Sector #169
Overall #2102
Operating Income Q/Q Growth Statistics
High Average Low
79375 % 1263.57 % -99.9 %
(March 31, 2010)  


PFE's IV. Quarter Q/Q Operating Income Comment
In the IV. Quarter 2020 Pfizer Inc disclosed fall in Operating Income from the third quarter by -89.74% to $ 341.00 millions, from $ 3,324.00 millions achived a quarter before.

As we evaluate present slump at the IV. Quarter, we should take into consideration, that commonly IV. Quarter 2020 results occur weaker then in the preciding period, Laura Álvarez, a business researcher mentioned.

Within Major Pharmaceutical Preparations industry 39 other companies have achieved higher Operating Income quarter on quarter growth. While Pfizer Inc's Operating Income growth quarter on quarter, overall rank is 2102.


Pfizer Inc's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 27 2020)
12 Months Ending
(Jun 28 2020)
12 Months Ending
(Mar 29 2020)
12 Months Ending
(Dec 31 2019)
Cumulative Operating Income 12 Months Ending $ 8,166.00 $ 12,055.00 $ 19,776.00 $ 20,951.00 $ 21,260.00
Y / Y Operating Income Growth (TTM) -61.59 % -45.3 % 34.02 % 44.83 % 51.85 %
Year on Year Operating Income Growth Overall Ranking # 1815 # 1650 # 408 # 330 # 234
Seqeuential Operating Income Change (TTM) -32.26 % -39.04 % -5.61 % -1.45 % -3.53 %
Seq. Operating Income Growth (TTM) Overall Ranking # 1109 # 1513 # 1293 # 1017 # 1189




Cumulative Operating Income growth Comment
Pfizer Inc's cumulative 12 months Operating Income continue to drop, but on the faster rate at -61.59% year on year, at Dec 31 2020 compare to the -45.3% decrease at Sep 27 2020. If the Pfizer Inc's fiscal year would end at Dec 31 2020, annual Operating Income would be $8,166 millions.

In the Healthcare sector 135 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 1650 to 1815.

Operating Income TTM Q/Q Growth Statistics
High Average Low
49.34 %
-0.76 %
-49.17 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 136
Overall # 1815

Operating Income TTM Y/Y Growth Statistics
High Average Low
52.51 %
3.49 %
-61.59 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 97
S&P 500 # 1109
Cumulative Operating Income growth Comment
Pfizer Inc's cumulative 12 months Operating Income continue to drop, but on the faster rate at -61.59% year on year, at Dec 31 2020 compare to the -45.3% decrease at Sep 27 2020. If the Pfizer Inc's fiscal year would end at Dec 31 2020, annual Operating Income would be $8,166 millions.

In the Healthcare sector 135 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 1650 to 1815.

Operating Income TTM Q/Q Growth Statistics
High Average Low
49.34 %
-0.76 %
-49.17 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 136
Overall # 1815

Operating Income TTM Y/Y Growth Statistics
High Average Low
52.51 %
3.49 %
-61.59 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 27
Sector # 97
S&P 500 # 1109




Other Operating Income Growth
Major Pharmaceutical Preparations Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
PFE's Operating Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for PFE's Competitors
Operating Income Growth for Pfizer Inc's Suppliers
Operating Income Growth for PFE's Customers

You may also want to know
PFE's Annual Growth Rates PFE's Profitability Ratios PFE's Asset Turnover Ratio PFE's Dividend Growth
PFE's Roe PFE's Valuation Ratios PFE's Financial Strength Ratios PFE's Dividend Payout Ratio
PFE's Roa PFE's Inventory Turnover Ratio PFE's Growth Rates PFE's Dividend Comparisons



Companies with similar Operating Income drop for the quarter ending Dec 31 2020 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2020
Check cap Ltd-0.97%$ -0.974 millions
Haemonetics Corp-1.18%$ -1.178 millions
Prestige Consumer Healthcare Inc -3.88%$ -3.875 millions
Pra Health Sciences Inc -4.22%$ -4.219 millions
Fonar Corp-4.36%$ -4.361 millions
Amgen Inc -5.53%$ -5.530 millions
Henry Schein Inc -7.71%$ -7.708 millions
Utah Medical Products Inc-8.51%$ -8.506 millions
Orthofix Medical Inc -9.52%$ -9.524 millions
Icon Plc-9.67%$ -9.669 millions
Encompass Health Corporation-10.41%$ -10.413 millions
Align Technology inc -10.75%$ -10.746 millions
Conmed Corporation-11.40%$ -11.399 millions
Radnet Inc -12.06%$ -12.064 millions
Corcept Therapeutics Inc-12.86%$ -12.861 millions
National Research Corporation-14.84%$ -14.839 millions
Kamada Ltd-15.57%$ -15.568 millions
Diversicare Healthcare Services Inc -15.76%$ -15.763 millions
Taro Pharmaceutical Industries Ltd-16.77%$ -16.765 millions
Davita Inc -17.49%$ -17.492 millions
Stryker Corp-20.66%$ -20.657 millions
Infusystem Holdings Inc-21.05%$ -21.053 millions
Genesis Healthcare Inc -21.41%$ -21.413 millions
National Healthcare Corp-22.54%$ -22.537 millions
Baxter International Inc -23.40%$ -23.396 millions
Pacific Health Care Organization Inc-23.89%$ -23.893 millions
Teleflex Incorporated-25.09%$ -25.094 millions
Healthcare Services Group Inc -25.61%$ -25.611 millions
Collplant Biotechnologies Ltd-26.63%$ -26.628 millions
Zimmer Biomet Holdings Inc -28.53%$ -28.533 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ALDX's Profile

Stock Price

ALDX's Financials

Business Description

Fundamentals

Charts & Quotes

ALDX's News

Suppliers

ALDX's Competitors

Customers & Markets

Economic Indicators

ALDX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071